MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Increased monosaccharide intake in patients with Parkinson’s disease

E. Schaeffer, A. Schermann, F. Zirbs, D. Berg (Tübingen, Germany)

Meeting: 2016 International Congress

Abstract Number: 291

Keywords: Behavioral abnormalities, Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinson's disease: Non-motor symptoms

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To verify the clinical observation that patients with Parkinson’s disease (PD) have a higher consumption of monosaccharides.

Background: Patients with PD frequently report an exceptionally high intake of monosaccharides, including mainly chocolate and other sweets. Exploring these behavioral changes may give new insights into pathophysiological mechanisms and may even provide treatment strategies for PD, as patients often describe better mobility after consumption of sweets.

Methods: Standardized questionnaires were used to assess and compare consumption of monosaccharides in a cohort of 221 PD patients and 184 healthy controls. Moreover medication, PD disease duration and possibly associated symptoms including impairment of taste and signs of hypoglycaemia were recorded.

Results: PD patients reported a significantly higher intake of chocolate (≥3-4 bars of chocolate per week in 14.0% of PD patients vs. 5.4% of controls; p=0.005) and of other sweets with a high proportion of monosaccharides (daily consumption in 68.8% of PD patients vs. 54.9% of controls; p=0.005). Comparison of male and female PD patients showed significantly higher daily sweet consumption in male PD patients (male = 75.6% vs. female= 58.9%; p = 0.012), whereas female PD patients reported more often feelings of regret after intake (male = 6.9% vs. female = 17.8%; p = 0.017). No group differences were seen for symptoms of hypoglycaemia or impairment of taste. High intake of monosaccharides was associated with significantly longer disease duration (no daily consumption: 3 years; 0-16 vs. daily consumption: 5 years; 0-20; p = 0.006).

Conclusions: PD patients have a higher intake of monosaccharides compared to controls. Higher consumption in male PD patients may be due to more prominent feelings of regret and consecutive restraint in female patients. Most interestingly, higher intake of monosaccharides was associated with longer PD disease duration. Efforts should be made to explore in a second step pathophysiological mechanisms behind these behavioral changes.

To cite this abstract in AMA style:

E. Schaeffer, A. Schermann, F. Zirbs, D. Berg. Increased monosaccharide intake in patients with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/increased-monosaccharide-intake-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/increased-monosaccharide-intake-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley